Skip to main content

Advertisement

SpringerLink
Log in

Genotype–Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Childhood and adolescent primary hyperparathyroidism (PHPT) is a very rare disease. Data on its molecular genetics are scarce. We performed a retrospective analysis (January 2000-January 2021) to determine the deleterious germline variants and genotype–phenotype correlations in children and adolescents < 20 years diagnosed with PHPT from a single referral center. Clinical features, biochemistry, imaging, management, and genetics (clinical exome analyzed for 11 PHPT and 7 pancreatitis-associated genes, MLPA for CDC73) were recorded. Thirty-six patients (20 males; median age 17 years) were classified into those with familial and/or syndromic (F/S) or apparently sporadic (AS) presentation. Sixteen (44.4%) harbored pathogenic/likely pathogenic germline variants in PHPT-associated genes. The genetic yield in F/S group was 90% (MEN1:8/10; CDC73:1/10), and AS group was 26.9% (CDC73:4/26; CASR:3/26). F/S group had frequent asymptomatic presentation (60% vs none; P < 0.001), lower serum PTH (237.5 vs 1369.1 pg/mL; P = 0.001), and maximum parathyroid dimension (0.9 vs 2.2 cm; P = 0.01) than AS group. Among the AS group, renal involvement was higher in those with molecular diagnoses (71.4% vs 10.5%; P = 0.01). All those with novel CASR variants (including one homozygous) had hypercalciuria and histology-proven parathyroid adenoma/carcinoma. A missense CTRC VUS occurred in one patient with chronic pancreatitis. In summary, Asian Indian children and adolescents with PHPT have high genetic yield, even with apparently sporadic presentation. The phenotypic spectrum of CASR variants is expanded to include childhood/adolescent PHPT with hypercalciuria and single gland neoplasia. The proposed roles for renal involvement to predict molecular diagnosis among those with apparently sporadic presentation require further elucidation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

Data Availability

Some or all datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

References

  1. Alagaratnam S, Kurzawinski TR (2015) Aetiology, diagnosis and surgical treatment of primary hyperparathyroidism in children new trends. Horm Res Paediatr. https://doi.org/10.1159/000381622

    Article  PubMed  Google Scholar 

  2. El Allali Y, Hermetet C, Bacchetta J et al (2021) Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population. Eur J Endocrinol 184:347–355. https://doi.org/10.1530/EJE-20-1119

    Article  PubMed  Google Scholar 

  3. Wang W, Kong J, Nie M et al (2017) Primary hyperparathyroidism in Chinese children and adolescents: A single-centre experience at Peking Union Medical College Hospital. Clin Endocrinol (Oxf) 87:865–873. https://doi.org/10.1111/cen.13453

    Article  CAS  Google Scholar 

  4. Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism. Nat Rev Dis Primer 2:16033. https://doi.org/10.1038/nrdp.2016.33

    Article  Google Scholar 

  5. Goudet P, Dalac A, Le Bras M et al (2015) MEN1 disease occurring before 21 years old: a 160-patient cohort study from the groupe d’étude des tumeurs endocrines. J Clin Endocrinol Metab 100:1568–1577. https://doi.org/10.1210/jc.2014-3659

    Article  CAS  PubMed  Google Scholar 

  6. Vannucci L, Marini F, Giusti F et al (2018) MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors. Endocrine 59:438–448. https://doi.org/10.1007/s12020-017-1322-5

    Article  CAS  PubMed  Google Scholar 

  7. Brandi ML, Agarwal SK, Perrier ND et al (2021) Multiple endocrine neoplasia type 1: latest insights. Endocr Rev 42:133–170. https://doi.org/10.1210/endrev/bnaa031

    Article  PubMed  Google Scholar 

  8. van der Tuin K, Tops CMJ, Adank MA et al (2017) CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism. J Clin Endocrinol Metab 102:4534–4540. https://doi.org/10.1210/jc.2017-01249

    Article  PubMed  Google Scholar 

  9. Guarnieri V, Canaff L, Yun FHJ et al (2010) Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years. J Clin Endocrinol Metab 95:1819–1829. https://doi.org/10.1210/jc.2008-2430

    Article  CAS  PubMed  Google Scholar 

  10. Frank-Raue K, Leidig-Bruckner G, Haag C et al (2011) Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 75:50–55. https://doi.org/10.1111/j.1365-2265.2011.04059.x

    Article  CAS  Google Scholar 

  11. Marx SJ (2019) New concepts about familial isolated hyperparathyroidism. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-02789

    Article  PubMed  PubMed Central  Google Scholar 

  12. Udelsman R, Åkerström G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3595–3606. https://doi.org/10.1210/jc.2014-2000

    Article  CAS  PubMed  Google Scholar 

  13. Marini F, Cianferotti L, Giusti F, Brandi ML (2017) Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update. Clin Cases Miner Bone Metab Off J Ital Soc Osteoporos Miner Metab Skelet Dis 14:60–70. https://doi.org/10.11138/ccmbm/2017.14.1.060

    Article  Google Scholar 

  14. Felderbauer P, Karakas E, Fendrich V et al (2011) Multifactorial genesis of pancreatitis in primary hyperparathyroidism: evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc 119:26–29. https://doi.org/10.1055/s-0030-1255106

    Article  CAS  Google Scholar 

  15. Mariathasan S, Andrews KA, Thompson E et al (2020) Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin Endocrinol (Oxf) 93:409–418. https://doi.org/10.1111/cen.14254

    Article  CAS  Google Scholar 

  16. National Kidney Foundation (2009) KDOQI clinical practice guideline for nutrition in children with CKD: 2008 Update. Am J Kidney Dis 53:S11–S104. https://doi.org/10.1053/j.ajkd.2008.11.017

    Article  Google Scholar 

  17. Banks PA, Bollen TL, Dervenis C et al (2013) Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut 62:102–111. https://doi.org/10.1136/gutjnl-2012-302779

    Article  PubMed  Google Scholar 

  18. Giraud S, Zhang CX, Serova-Sinilnikova O et al (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 63:455–467. https://doi.org/10.1086/301953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tanaka C, Yoshimoto K, Yamada S et al (1998) Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endocrinol Metab 83:960–965. https://doi.org/10.1210/jcem.83.3.4653

    Article  CAS  PubMed  Google Scholar 

  20. Agarwal SK, Kester MB, Debelenko LV et al (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6:1169–1175. https://doi.org/10.1093/hmg/6.7.1169

    Article  CAS  PubMed  Google Scholar 

  21. Domingues R, Tomaz RA, Martins C et al (2012) Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol (Oxf) 76:33–38. https://doi.org/10.1111/j.1365-2265.2011.04184.x

    Article  CAS  Google Scholar 

  22. Bricaire L, Odou M-F, Cardot-Bauters C et al (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:E403-408. https://doi.org/10.1210/jc.2012-2789

    Article  CAS  PubMed  Google Scholar 

  23. Rosendahl J, Witt H, Szmola R et al (2008) Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 40:78–82. https://doi.org/10.1038/ng.2007.44

    Article  CAS  PubMed  Google Scholar 

  24. Shattuck TM, Välimäki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722–1729. https://doi.org/10.1056/NEJMoa031237

    Article  CAS  PubMed  Google Scholar 

  25. Rekik N, Ben Naceur B, Mnif M et al (2010) Hyperparathyroidism-jaw tumor syndrome: a case report. Ann Endocrinol 71:121–126. https://doi.org/10.1016/j.ando.2009.09.004

    Article  CAS  Google Scholar 

  26. Sadacharan D, Mahadevan S, Rao SS et al (2020) Neonatal severe primary hyperparathyroidism: a series of four cases and their long-term management in India. Indian J Endocrinol Metab 24:196–201. https://doi.org/10.4103/ijem.IJEM_53_20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kulkarni A, Mohite M, Vijaykumar R et al (2014) Neonatal severe hyperparathyroidism due to compound heterozygous mutation of calcium sensing receptor (CaSR) gene presenting as encephalopathy. Indian J Pediatr 81:1228–1229. https://doi.org/10.1007/s12098-014-1442-3

    Article  PubMed  Google Scholar 

  28. Sethi BK, Nagesh VS, Kelwade J et al (2017) Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia. Indian J Endocrinol Metab 21:362–363. https://doi.org/10.4103/2230-8210.202034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Alam S, Goyal A, Tandon N (2021) Clinical, Biochemical, and Genetic Profile of an Indian Kindred with Type 1 Familial Hypocalciuric Hypercalcemia. Indian J Endocrinol Metab 25:462–465. https://doi.org/10.4103/ijem.ijem_349_21

    Article  PubMed  Google Scholar 

  30. Goroshi M, Bandgar T, Lila AR et al (2016) Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Fam Cancer 15:617–624. https://doi.org/10.1007/s10689-016-9891-7

    Article  CAS  PubMed  Google Scholar 

  31. Shyamasunder AH, Pai R, Ramamoorthy H et al (2021) Clinical Profile and mutations associated with multiple endocrine neoplasia-Type1 (MEN1) and their first-degree relatives at risk of developing MEN1: A prospective study. Horm Metab Res Horm Stoffwechselforschung Horm Metab 53:245–256. https://doi.org/10.1055/a-1402-0183

    Article  CAS  Google Scholar 

  32. Newey PJ, Bowl MR, Cranston T, Thakker RV (2010) Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat 31:295–307. https://doi.org/10.1002/humu.21188

    Article  CAS  PubMed  Google Scholar 

  33. Haven CJ, van Puijenbroek M, Karperien M et al (2004) Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J Pathol 202:86–94. https://doi.org/10.1002/path.1489

    Article  CAS  PubMed  Google Scholar 

  34. Ho C, Conner DA, Pollak MR et al (1995) A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389–394. https://doi.org/10.1038/ng1295-389

    Article  CAS  PubMed  Google Scholar 

  35. Mouly C, Vargas-Poussou R, Lienhardt A et al (2020) Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin Endocrinol (Oxf) 93:248–260. https://doi.org/10.1111/cen.14211

    Article  CAS  Google Scholar 

  36. Hannan FM, Nesbit MA, Christie PT et al (2010) A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Clin Endocrinol (Oxf) 73:715–722. https://doi.org/10.1111/j.1365-2265.2010.03870.x

    Article  CAS  Google Scholar 

  37. Miyashiro K, Kunii I, Manna TD et al (2004) Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 89:5936–5941. https://doi.org/10.1210/jc.2004-1046

    Article  CAS  PubMed  Google Scholar 

  38. Chikatsu N, Fukumoto S, Suzawa M et al (1999) An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor. Clin Endocrinol (Oxf) 50:537–543. https://doi.org/10.1046/j.1365-2265.1999.00729.x

    Article  CAS  Google Scholar 

  39. Aida K, Koishi S, Inoue M et al (1995) Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrinol Metab 80:2594–2598. https://doi.org/10.1210/jcem.80.9.7673400

    Article  CAS  PubMed  Google Scholar 

  40. Lietman SA, Tenenbaum-Rakover Y, Jap TS et al (2009) A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 94:4372–4379. https://doi.org/10.1210/jc.2008-2484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Szczawinska D, Schnabel D, Letz S, Schöfl C (2014) A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets. J Clin Endocrinol Metab 99:E1146-1153. https://doi.org/10.1210/jc.2013-3593

    Article  CAS  PubMed  Google Scholar 

  42. Maltese G, Izatt L, McGowan BM et al (2017) Making (mis) sense of asymptomatic marked hypercalcemia in pregnancy. Clin Case Rep 5:1587–1590. https://doi.org/10.1002/ccr3.1074

    Article  PubMed  PubMed Central  Google Scholar 

  43. Borsari S, Marcocci C, Cetani F (2017) Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene. J Endocrinol Invest 40:1271–1272. https://doi.org/10.1007/s40618-017-0710-2

    Article  CAS  PubMed  Google Scholar 

  44. Schnabel D, Letz S, Lankes E et al (2014) Severe but not neonatally lethal. A homozygous inactivating CaSR mutation in a 3 year old child. Exp Clin Endocrinol Diabetes 122:041. https://doi.org/10.1055/s-0034-1372058

    Article  Google Scholar 

  45. Zhou J, Sahin-Tóth M (2011) Chymotrypsin C mutations in chronic pancreatitis. J Gastroenterol Hepatol 26:1238–1246. https://doi.org/10.1111/j.1440-1746.2011.06791.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge Dr. Aparna Kamble for administrative help in the study’s conduct and Samiksha Chandrashekhar Hegishte for help in the review of genetic data.

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, 400012, India

    Anima Sharma, Saba Memon, Anurag R. Lila, Sneha Arya, Vikrant Gosavi, Manjiri Karlekar, Virendra Patil & Tushar Bandgar

  2. Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, 560066, India

    Vijaya Sarathi

  3. Department of Endocrinology, Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru, 560090, India

    Swati S. Jadhav

  4. Department of Radiodiagnosis, Seth GS Medical College and KEM Hospital, Parel, Mumbai, India

    Priya Hira

  5. Department of Surgery, Seth GS Medical College and KEM Hospital, Parel, Mumbai, India

    Mahadeo Garale

Authors
  1. Anima Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saba Memon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anurag R. Lila
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vijaya Sarathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sneha Arya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Swati S. Jadhav
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Priya Hira
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mahadeo Garale
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vikrant Gosavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Manjiri Karlekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Virendra Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tushar Bandgar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The corresponding author had full access to all of the data in the study and took responsibility for the decision to submit the article for publication. All authors participated in the study design, conducted the study, and contributed to data acquisition. AS, SM, ARL, VS, and TB interpreted the data and drafted the first manuscript. All authors revised the manuscript for important intellectual content and interpreted the data. All authors approved the final version of the manuscript and agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are appropriately investigated and resolved.

Corresponding author

Correspondence to Tushar Bandgar.

Ethics declarations

Conflict of interest

Anima Sharma, Saba Memon, Anurag R Lila, Vijaya Sarathi, Sneha Arya, Swati S Jadhav, Priya Hira, Mahadeo Garale, Vikrant Gosavi, Manjiri Karlekar, Virendra Patil, and Tushar Bandgar declare that they have no conflicts of interest.

Ethical Approval

The study was approved by the Institutional Ethics Committee [IEC(II)/OUT/175/2021 project number EC/OA-25/2021].

Informed Consent

Obtaining informed consent from participants was not applicable and was waived by Institutional Ethics Committee as this was a retrospective record study.

Human and Animal Rights

The research was performed in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee [IEC(II)/OUT/175/2021 project number EC/OA-25/2021].

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 89 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, A., Memon, S., Lila, A.R. et al. Genotype–Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism. Calcif Tissue Int 111, 229–241 (2022). https://doi.org/10.1007/s00223-022-00985-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-022-00985-x

Keywords

Search

Navigation